Please assess the completion status of the following clinical trial:

Trial Title: Financial Incentives for Smoking Cessation Among Mothers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Expresses interest in quitting smoking~* Express willingness to initiate NRT~* Mother is ≥ 18 years of age~* Self-reported smoking ≥ 10 cigarettes per day for ≥ 1 year, biochemically verified~* Mother has a child \< 12 years of age~* Child resides with mother full-time~* Not currently using any other tobacco cessation medications (e.g. Chantix) or NRT, or willing to stop use prior to participation in the study~* Lives in Chittenden County, Vermont or surrounding counties~* Plans on remaining in the geographical area for the next 12 months~* English-speaking~* Willing to let child participate in the study~Exclusion Criteria:~* Failing to meet any of the above criteria~* Has medical contraindications to NRT products~* Meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for moderate or severe alcohol or drug dependence other than nicotine in the prior 12 months (those on opioid substitution therapy are allowed)~* Current/past psychotic disorder~* Being suicidal~* Currently pregnant or trying to become pregnant in the next 12 months~* Incarceration~* Refusal to participate in study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Best practices (Type: EXPERIMENTAL): Participants will receive the Five As plus a referral to a quit line.
- Best practices and financial incentives (Type: EXPERIMENTAL): Participants will receive the Five As, a referral to a quit line, and financial incentives contingent on biochemically confirmed smoking abstinence
- Best practices, financial incentives, and NRT (Type: EXPERIMENTAL): Participants will receive the Five As, a referral to a quit line, financial incentives contingent on biochemically confirmed smoking abstinence, and nicotine replacement therapy (NRT) provided in the form of both nicotine patches and gum/lozenge for dual therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).